Events2Join

The Changing Face of Leadership in China's Medtech Sector


The Changing Face of Leadership in China's Medtech Sector

China's medtech industry is facing complex new challenges. To meet them, companies need to cultivate adaptable and diverse leaders who can shape local ...

Ran Wu on LinkedIn: The Changing Face of Leadership in China's ...

NEWS ASIA The MedTech Industry in India: Outlook and Growth Drivers India's medical device market is experiencing significant expansion with the ...

Alejandro Folmer on LinkedIn: The Changing Face of Leadership in ...

China's MedTech industry has grown rapidly over the past decade and shows no sign of slowing down, continuing to drive bold innovations in both diagnosis ...

The govt is reshaping China's medical technology industry

Volume-based procurement is transforming the MedTech industry in China · The Chinese government is conducting healthcare provider reforms by ...

How COVID-19 is reshaping China's medtech industry | McKinsey

Leading up to 2020, VBP had made it to the top of the agenda of China's medtech leaders. In January 2020, the scope and impact led many to ...

China In The Global Medtech Industry Equal Parts Promising And ...

International medtech companies face challenges in accessing the Chinese market due to the preference for locally manufactured products. The ...

Upgrading medtech commercial operations in China | McKinsey

While multinational medtech participants in China and domestic companies in this critical industry continue to deliver essential healthcare ...

China medtech product launches: 4 factors for market success - ZS

Based on past ZS research and an assessment of medtech launch cases in China, we find a path to success exists for MNC new launches. Neither ...

China's new business leaders - Korn Ferry

Developing leadership is one of the greatest challenges facing all types of Chinese organizations, from state- and private-owned local Chinese firms to ...

China on the Way to Global Technology Leadership - PMC

... market of new technologies. The problems that China faces along this path, including the phenomenon of “junk” patents, are highlighted. The ...

V4_Chinas V4 Healthcare Innovation by Made in China 2025 and ...

likely face an important trade-off between market opportunity and ... China opportunities, and a new Market Authorization Holder regime reduces investment.

Winning in China's Changing Medtech Market

The China Food and Drug Administration (CFDA) wants to encourage innovation across the health care industry. While it will likely be several ...

THE CHINESE MEDTECH SECTOR - IberChina

One of the major hurdles to enter the Chinese medtech market is the new regulatory rules under Order 650 which require clinical trials for ...

Investigating state support for China's medical technology companies

... China's MedTech firms a significant boost China is developing a new blend of state capitalism to guide financial markets toward national ...

Insights into Chinese Medical Device Companies Going Global

Jens Ewert, Deloitte China Life Sciences & Health Care Industry leader, says, "The goal in globalization of Chinese medical device companies is ...

China on the Move: New Level of Opening up in Health Care Sector

Lift Barriers for Foreign Investment in Cell and Gene Therapy and Hospitals · China to Overhaul Medical Device Regulatory Framework: A New Era of ...

Successes and challenges of China's health care reform

In terms of health sector this means that global demand and supply of medical goods, services and pharmaceuticals remains largely driven by ...

Going Global: Talent Advice from China's Healthcare ...

At the end of 2021, China issued a development plani for the healthcare industry, pointing out the need for Chinese healthcare companies to ...

Why China is making innovation the new engine of growth

According to the 2023 Global Innovation Index of the World Intellectual Property Organization, 24 Chinese science and technology clusters made ...

The Changing Face of Innovation in China

Generally speaking, foreign companies traditionally have not transferred cutting-edge technology to China and conducted R&D on it there.19 These ...